FDA approved a drug based on UVA research led by Xuemei Huang.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA approved a drug based on UVA research led by Xuemei Huang.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Xuemei Huang
researcher (ORCID 0000-0002-7112-6407)
Nothing else this week.
Related events
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
- Experimental therapies require approval from the FDA.
- The FDA recommended advancement for a new drug application submitted by a company.
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.